MyFinsight
Home
Blog
About
Cash and cash
equivalents
$10,443K
(-37.97%↓ Y/Y)
Prepaid and other
current assets
$570K
(-76.39%↓ Y/Y)
Total current assets
$11,013K
(-55.74%↓ Y/Y)
Property and equipment,
net
$14K
(-70.83%↓ Y/Y)
Total assets
$11,027K
(-56.17%↓ Y/Y)
Total liabilities,
non-controlling interests and...
$11,027K
(-56.17%↓ Y/Y)
Total equity
$7,990K
(-61.54%↓ Y/Y)
Total liabilities
$3,037K
(-30.74%↓ Y/Y)
Non-controlling interests
-$254K
(0.00%↑ Y/Y)
Total lisata
therapeutics, inc....
$8,244K
(-60.80%↓ Y/Y)
Total current
liabilities
$2,987K
(-30.74%↓ Y/Y)
Other long-term
liabilities
$50K
(-30.56%↓ Y/Y)
Accumulated deficit
-$572,070K
(-2.62%↓ Y/Y)
Treasury stock, at cost
738 shares at june...
$708K
(0.00%↑ Y/Y)
Accumulated other
comprehensive loss
-$17K
(66.00%↑ Y/Y)
Additional paid-in capital
$581,030K
(0.31%↑ Y/Y)
Accrued liabilities
$2,151K
(-39.08%↓ Y/Y)
Accounts payable
$836K
(6.91%↑ Y/Y)
Common stock, 0.001 par
value, authorized...
$9K
(0.00%↑ Y/Y)
Back
Back
Balance Sheet
LISATA THERAPEUTICS, INC. (LSTA)
LISATA THERAPEUTICS, INC. (LSTA)
source: myfinsight.com